TAFINLAR

Identification of Tafinlar

Please sign up for a free trial to see the description of this product.

Examples of the descriptions of OTHER drugs:

Lipitor 10 mg

Apo-Irbesartan 150 mg

Crestor 20 mg

Google image searchProduct monograph

Active ingredient

dabrafenib (dabrafenib mesylate), 75 MG

DIN: 02409615

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 04-MAY-2016

ATC:

L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
L01EC — B-Raf serine-threonine kinase (BRAF) inhibitors (ATC, ATC/DDD)
L01EC02 — DABRAFENIB (ATC/DDD)

Reference brand drug: Tafinlar

External Links for Tafinlar

Search on Google

Tafinlar side effects
Tafinlar dosage
dabrafenib side effects
dabrafenib dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find tafinlar photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.